American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 196 | 92 | 108 | 11 | -376 |
| Depreciation Amortization | 376 | 279 | 188 | 95 | 378 |
| Accounts receivable | 58 | -54 | -464 | -45 | -262 |
| Accounts payable and accrued liabilities | -288 | -324 | -602 | -700 | 23 |
| Other Working Capital | -257 | 240 | -464 | -364 | -597 |
| Other Operating Activity | 257 | 399 | 1,095 | 745 | 462 |
| Operating Cash Flow | $342 | $632 | $-139 | $-258 | $-372 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -803 | -334 | -12 | -6 | -133 |
| Investing Cash Flow | $-803 | $-334 | $-12 | $-6 | $-133 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 176 | 103 | 230 | 359 | N/A |
| Debt Issued | 775 | N/A | N/A | N/A | 25 |
| Debt Repayment | -627 | -26 | -19 | -15 | -71 |
| Common Stock Issued | 332 | 85 | 85 | N/A | 3 |
| Financing Cash Flow | $656 | $162 | $296 | $344 | $-43 |
| Beginning Cash Position | 446 | 446 | 446 | 446 | 995 |
| End Cash Position | 641 | 906 | 591 | 526 | 446 |
| Net Cash Flow | $195 | $460 | $145 | $80 | $-548 |
| Free Cash Flow | |||||
| Operating Cash Flow | 342 | 632 | -139 | -258 | -372 |
| Capital Expenditure | -803 | -334 | -12 | -6 | -133 |
| Free Cash Flow | -461 | 298 | -151 | -264 | -505 |